In one paragraphArticle in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Quxiang LiSchool of Pharmacy, Nanjing Tech University, 30th South Puzhu Road, Nanjing 211816, China.ORCID 0009-0006-7662-6319 Dongli WangJiangsu Key Laboratory of Central Nervous System Drug Research and Development, Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, China.ORCID 0000-0002-5038-6218 Junyong LuoSchool of Pharmacy, Nanjing Tech University, 30th South Puzhu Road, Nanjing 211816, China.ORCID 0009-0006-5669-9510 Changda XuJiangsu Key Laboratory of Central Nervous System Drug Research and Development, Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, China.ORCID 0009-0005-9083-1987 Jian FengJiangsu Key Laboratory of Central Nervous System Drug Research and Development, Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, China.ORCID 0009-0002-3312-0343 Xiangqing XuJiangsu Key Laboratory of Central Nervous System Drug Research and Development, Institute of Pharmaceutical Research, Jiangsu Nhwa Pharmaceutical Co., Ltd., Xuzhou 221116, China.ORCID 0000-0003-3778-0824 Guoguang ChenSchool of Pharmacy, Nanjing Tech University, 30th South Puzhu Road, Nanjing 211816, China.
Funding
National Science and Technology Major Project (2017ZX0931057), Jiangsu key R&D plan (BE2019738), National Key R&D Program of China (2023YFF0723400) and Jiangsu Key Laboratory of Central Nervous System Drug Research and Development (BM2019004) 2017ZX0931057,BE2019738,2023YFF0723400,BM2019004
6 · The paper itselfAbstract
In this research, a variety of novel amphetamine derivatives were synthesized and assessed for their potential as multifaceted antidepressant agents. Among these compounds, compound
Indexed as
Antidepressive AgentsMolecular Docking SimulationReceptors, Histamine H3Serotonin Plasma Membrane Transport ProteinsAmphetamineAmphetaminesAnimalsCentral Nervous SystemHumansMaleMiceNorepinephrine Plasma Membrane Transport ProteinsRatsStructure-Activity RelationshipAmphetamineAmphetaminesAntidepressive AgentsNorepinephrine Plasma Membrane Transport ProteinsReceptors, Histamine H3Serotonin Plasma Membrane Transport Proteinsamphetamineantidepressantmolecular dockingmultitarget
Identifiers
PMID39598630
PMCPMC11870037
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390